Academic Research_Academic Research_Jiangsu Recbio Technology Co., Ltd.

Investor Relations
Corporate Governance Stock Information Announcement and circular Prospectus
CN

Investor Relations 
Corporate Governance Stock Information Announcement and circular Prospectus
CN

Academic Research

RecBio is a high-tech enterprise jointly founded by the former vaccine R & D expert team from the Chinese Center for Disease Control and Prevention (China CDC) and the senior vaccine industrialization team.
The company has established a leading domestic R & D and innovation platform for new adjuvants, genetic engineering, and immune evaluation.

Learn about the Vaccines

To Learn Immunology Well: Section 4
Time of issue : 2021-02-22
To Learn Immunology Well: Section 3
Time of issue : 2021-02-03
To Learn Immunology Well: Section 2
Time of issue : 2021-02-02
To Learn Immunology Well: Section 1
Time of issue : 2021-01-29
Infectious Disease Vaccines and Development Trend
Time of issue : 2020-11-30

Contact Us

底部联系方式

Time of issue:2022-03-29 08:59:20

Jiangsu Recbio Technology Co., Ltd.

Media Inquiry: media@recbio.cn

Investor Inquiry: ir@recbio.cn

Address: Vaccine Engineering Center, China Medical City, Taizhou

Learn about the Vaccines

底部联系方式